Effects of different dose levels and vaccination schedules on immune response to a recombinant DNA hepatitis B vaccine in haemodialysis patients
- 31 March 1990
- Vol. 8, S47-S49
- https://doi.org/10.1016/0264-410x(90)90218-b
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- More about Response to Hepatitis B Vaccine in Hemodialysis PatientsNephron, 1988
- Clinical and immunologic features of chronic dialysis patients who fail to respond to hepatitis B vaccineVaccine, 1985
- Active hepatitis B vaccination of dialysis patients and medical staffKidney International, 1984
- Immunogenicity of a hepatitis B subunit vaccine in hemodialysis and in renal transplant recipientsAntiviral Research, 1983
- RANDOMISED PLACEBO-CONTROLLED TRIAL OF HEPATITIS B SURFACE ANTIGEN VACCINE IN FRENCH HAEMODIALYSIS UNITS: II, HAEMODIALYSIS PATIENTSThe Lancet, 1981
- HEPATITIS B VACCINE: IMMUNE RESPONSES IN HAEMODIALYSIS PATIENTSThe Lancet, 1980
- Duration of hepatitis B surface antigenemia (HBs Ag) in hemodialysis patientsArchives of internal medicine (1960), 1979
- Hepatitis B Virus Markers in 97 Long-Term Hemodialysis PatientsNephron, 1979
- Hemodialysis-Associated Hepatitis in the United States, 1974The Journal of Infectious Diseases, 1977
- Hepatitis B infection. A point-prevalence study in 15 US hemodialysis centersPublished by American Medical Association (AMA) ,1974